Serum Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

January 25, 2018

Primary Completion Date

April 16, 2019

Study Completion Date

April 16, 2019

Conditions
Heart Failure,Congestive
Interventions
DIAGNOSTIC_TEST

Blood withdrawal for laboratory analysis

"Participants in this study will have their peripheral blood sampled from the cubital vein and the total volume withdrawn for the purposes of this study will be no more than 22 mL per person.~Parameters of interest in the laboratory analysis will include serum catestatin levels, NT-proBNP levels, hs-cTnI, parameters of inflammation and renal function as well as standard biochemistry and complete blood count (CBC) panels."

OTHER

Standard-of-care treatment

Patients diagnosed with chronic heart failure will receive optimal standards of care in terms of pharmacologic management, according to their current clinical condition.

DIAGNOSTIC_TEST

Transthoracic echocardiography (TTE)

Participants from both groups will undergo transthoracic echocardiography examination that will measure established hemodynamic parameters of systolic and diastolic cardiac function as well as parameters of LV and RV strain in the selected subset of patients.

Trial Locations (1)

21000

University Hospital of Split, Split

All Listed Sponsors
collaborator

University of Split, School of Medicine

OTHER

lead

Josko Bozic

OTHER

NCT03389386 - Serum Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure | Biotech Hunter | Biotech Hunter